𝔖 Bobbio Scriptorium
✦   LIBER   ✦

20q13.2 Amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast

✍ Scribed by M. Werner; Anita Mattis; Michaela Aubele; Margaret Cummings; Horst Zitzelsberger; Peter Hutzler; Heinz Höfler

Publisher
Springer
Year
1999
Tongue
English
Weight
835 KB
Volume
435
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The molecular journey from ductal carcin
The molecular journey from ductal carcinoma in situ to invasive breast cancer
✍ Lisa Wiechmann; Henry M. Kuerer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 767 KB

## Abstract Ductal carcinoma in situ (DCIS) accounts for approximately 20% of mammographically detected breast cancers. DCIS can recur or progress to invasive breast cancer, but the ability to predict the outcome of patients with DCIS remains limited, leading to inappropriate treatment choices. To

Aberrant expression of muc1 mucin in duc
Aberrant expression of muc1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast
✍ Ellen C.M. Mommers; Angelique M. Leonhart; Silvia von Mensdorff-Pouilly; Dick J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 91 KB 👁 2 views

MUC1 mucin is a high molecular weight transmembrane glycoprotein expressed on the apical cell surface of normal glandular epithelia. In many human adenocarcinomas, this protein is up-regulated and/or underglycosylated, and its expression changes from apical to the entire cell membrane. It is thought